Dry eye common in early GO

Article

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

According to recent data, dry eye has been found to be common in patients with early Graves Ophthalmology (GO).

Dr Vasilis Achtsidis et al., Attikon University Hospital, University of Athens, Greece, evaluated a total of 52 eyes of 26 patients with early GO and 37 control subjects. GO diagnosis was based on the European Group on Graves Orbitopathy consensus statement. The team also calculated Clinical Activity Score (CAS) and Werner-NOSPECS Score, as well as corneal sensitivity using a Cochet-Bonnet aesthesiometer.

Of the participants included in the study, 67.8% with early GO and 13.5% of healthy controls presented with ocular surface dryness. Mean Schirmer test scores were significantly lower in GO patients, compared to controls and these results correlated with CAS. Tear film break up time was lower in patients by 5.46 seconds and 5.74 seconds in the right and left eyes, respectively.

Dry eye is common in GO, despite the absence of apparent exophthalmos, and based on the results the team concluded that there was an association with CAS as well as reduced corneal sensitivity.

To read the abstract please visit the European Journal of Ophthalmology.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Alfredo Sadun, MD, PhD, chief of Ophthalmology at the Doheny Eye Institute, University of California Los Angeles, shared exciting new research with the Eye Care Network during the Association for Research in Vision and Ophthalmology (ARVO) meeting on the subject of Leber hereditary optic neuropathy (LHON).
At this year's Association for Research in Vision and Ophthalmology (ARVO) meeting in Salt Lake City, Utah, Nitish Mehta, MD, shared highlights from his research documenting real-world results of aflibercept 8 mg for patients with diabetic macular oedema.
ARVO 2025: Anat Loewenstein, MD, shares data from herself and her colleagues on meeting needs of patients with diabetic retinopathy
At the American Society of Cataract and Refractive Surgeons annual meeting, Sheng Lim, MD, FRCOphth discusses the benefit of endoscopic cyclophotocoagulation for patients with primary open angle glaucoma and cataracts in the CONCEPT study
A photo of Seville, Spain, with the Congress on Controversies in Ophthalmology logo superimposed on it. Image credit: ©francovolpato – stock.adobe.com; logo courtesy COPHy
Anat Loewenstein, MD, Professor and Director, Department of Ophthalmology, Tel Aviv Medical Center, discusses the Congress on Controversies in Ophthalmology (COPHy)
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
© 2025 MJH Life Sciences

All rights reserved.